CIM LLC’s RxSight RXST Stock Holding History

CIM LLC’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,203	Closed	-$207K	–	176
2025 Q1	$207K	Buy	8,203 +165	+2%	+$4.9K	0.03%	154
2024 Q4	$276K	Buy	8,038 +178	+2%	+$8.03K	0.04%	149
2024 Q3	$389K	Sell	7,860 -58	-0.7%	-$2.97K	0.06%	126
2024 Q2	$424K	Buy	+7,918	New	+$452K	0.06%	116

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIM LLC's RXST Position: Q2 2025 in Review

CIM LLC sold out of RxSight (RXST) in Q2 2025, closing a stake of 8,203 shares — an estimated $207K sold.

CIM LLC first reported a position in RXST in Q2 2024 and held it in 4 quarters. The position peaked at $424K in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

CIM LLC reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
CIM LLC sold 8,203 RxSight shares in Q2 2025, an estimated $207K.
CIM LLC first reported a position in RxSight in Q2 2024 and held it in 4 quarters.
CIM LLC's RxSight position peaked at $424K in Q2 2024.
174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on CIM LLC's 13F filing for Q2 2025, filed 19 Aug 2025.